Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-29

Clinical Trial Update: COGNUTRIN in Breast Cancer Survivors [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial update for COGNUTRIN in breast cancer survivors; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COGNUTRIN

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-08-29